Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Cadila gets USFDA nod for depression tab Risperidone


      Mumbai, Oct 20 : Pharmaceutical company Cadila Healthcare today said that its parent firm Zydus Cadila has received US Food and Drug Administration (USFDA) approval to market Risperidone Tablets, used to treat depression.

      Risperidone falls in the central nervous system (CNS) segment, Cadila Healthcare stated in a filing to the Bombay Stock Exchange.

      The group now has 41 approvals and has so far filed for 79 Abbreviated New Drug Application's (ANDA), it added.

      Last week, Zydus Cadila filed an Investigational New Drug application with the Drugs Controller General of India for ZYT 1, which is used to prevent heart attack and stroke.

      Shares of the Company were trading at Rs 258, down 2.69 per cent in the noon session on the Bombay Stock Exchange.

      October 29, 2008


      Share this Article!

    Back to top^